LL-37 Protocol
Dosing & Research
Last Updated: September 4, 2026
Antimicrobial defense research, Wound repair, Biofilm and immune-signaling studies, Inflammation modulation
Half-Life
~30 Minutes (plasma)
Administration
• Topical
• Injection
Frequency
Daily To Twice Weekly Based On Wound Type
How It Works
- Antimicrobial defense research
- Wound repair
- Biofilm and immune-signaling studies
- Inflammation modulation
Dosing Structure
Dose
0.5–1.6 mg/mL
Frequency
Daily To Twice Weekly Based On Wound Type
Notes
Continue Until Complete Healing Achieved.
Example Protocols
Dose: 0.5–1.6 mg/mL
Frequency: Daily To Twice Weekly Based On Wound Type
Duration: 2-8 weeks depending on healing progress
Off Period: Not listed
Find Research Grade LL-37
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
Continue until complete healing achieved.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.